Skip to content
Visit us at
www.anandandanand.com
Search
PATENTS REWIND : AN ANAND AND ANAND BLOG
Category:
Pharmaceuticals
Non-compliant defendants face permanent injunction
CCI orders Investigation against Roche
DHC maintains the injunction on Cipla for Onbrez
DHC maintains the injuction on Cipla For Onbrez
Export within ambit of Bolar exemption
Trastuzumab “can” be sold as a bio similar to Roche’s Trastuzumab
Writ for Enzalutamide admitted by the DHC
Cancer drug (Enzalutamide) Patent application refused
Etanercept applications granted by the IPO
Guidelines on Similar Biologics
Previous Page
Next Page
Subscribe
Subscribed
Patents Rewind - An Anand and Anand Blog
Join 108 other subscribers
Sign me up
Already have a WordPress.com account?
Log in now.
Patents Rewind - An Anand and Anand Blog
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
Patents Rewind - An Anand and Anand Blog 